Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. I. Social interactions.

作者: MG Cutler , RJ Rodgers , JE Jackson

DOI: 10.1016/S0091-3057(96)00241-9

关键词:

摘要: Abstract In a continuation of recent work on effects benzodiazepine (chlordiazepoxide) and selective monoamine reuptake inhibitors (maprotiline fluvoxamine), the current study compares 5-HT 1A receptor partial agonist, buspirone (0.75–3.0 mg/kg), 3 antagonist, ondansetron (0.1–100 μg/kg) novel antidepressant, tianeptine (2.5–10.0 mg/kg). Compounds were given daily to mice for 21 days prior testing subsequent behaviour animals during social interactions was assessed by ethopharmacological procedures. Buspirone, at 0.75 mg/kg, increased immobility reduced occurrence aggressive act, “attack.” At 1.5 3.0 it enhanced olfactory exploration sawdust substrate, but had no effect investigation. Ondansetron duration environmental 0.1 μg/kg, while 100 μg/kg digging in substrate. categories failed induce an anxiolytic-like enhancement Tianeptine produced anxiogenic-like 10 5 mg/kg flight immobility. The relevance these findings is discussed relation reported behavioural actions compounds pharmacotherapy anxiety depression. apparent anxiogenic finding which requires further study.

参考文章(47)
Hugh C. Hendrie, S. J. Cooper, Ethology and psychopharmacology J. Wiley & Sons. ,(1994)
G. Invernizzi, E. Aguglia, A. Bertolino, M. Casacchia, N. Ciani, G.F. Marchesi, M. Nardini, V. Rapisarda, The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline. Neuropsychobiology. ,vol. 30, pp. 85- 93 ,(1994) , 10.1159/000119142
Karl Rickels, Antidepressants for the Treatment of Generalized Anxiety Disorder Archives of General Psychiatry. ,vol. 50, pp. 884- 895 ,(1993) , 10.1001/ARCHPSYC.1993.01820230054005
M.G. Cutler, R.J. Rodgers, J.E. Jackson, Behavioural Effects in Mice of Subchronic Chlordiazepoxide, Maprotiline, and Fluvoxamine. I. Social Interactions Pharmacology, Biochemistry and Behavior. ,vol. 57, pp. 119- 125 ,(1997) , 10.1016/S0091-3057(96)00135-9
C. D. Kilts, R. L. Commissaris, R. H. Rech, Comparison of anti-conflict drug effects in three experimental animal models of anxiety Psychopharmacology. ,vol. 74, pp. 290- 296 ,(1981) , 10.1007/BF00427112
Thomas J. Feuerstein, Georg Hertting, Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 333, pp. 191- 197 ,(1986) , 10.1007/BF00512929
M. BRILEY, New concepts in anxiety Journal of Pharmacy and Pharmacology. ,vol. 42, pp. 453- 455 ,(1991) , 10.1111/J.2042-7158.1990.TB06593.X
Arlene S. Eison, Davis L. Temple, Buspirone: review of its pharmacology and current perspectives on its mechanism of action The American Journal of Medicine. ,vol. 80, pp. 1- 9 ,(1986) , 10.1016/0002-9343(86)90325-6